A role for protein kinase C-mediated phosphorylation in eliciting glucagon desensitization in rat hepatocytes

A. Savage, L. Zeng, M. D. Houslay

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

An immobilized hepatocyte preparation was used to show that both vasopressin and glucagon could desensitize the ability of glucagon to increase intracellular cyclic AMP concentrations. This process was not dependent on any influx of extracellular Ca2+ and was not mediated by any rise in the intracellular level of Ca2+. The protein kinase C-selective inhibitors chelerythrine, staurosporine and calphostin C acted as potent inhibitors of the desensitization process but with various degrees of selectivity regarding their ability to inhibit the desensitizing actions of glucagon and vasopressin. The protein phosphatase inhibitor okadaic acid was just as potent as vasopressin and glucagon in causing desensitization. Treatment of hepatocyte membranes with alkaline phosphatase restored to near control levels the ability of glucagon to stimulate adenylate cyclase activity in membranes from both glucagon- and vasopressin-treated (desensitized) hepatocytes. It is suggested that the desensitization of glucagon-stimulated adenylate cyclase activity involves a reversible phosphorylation reaction with the likely target being the glucagon receptor itself.
Original languageEnglish
Pages (from-to)281-285
Number of pages5
JournalBiochemical Journal
Volume307
Issue number1
DOIs
Publication statusPublished - 1 Apr 1995
Externally publishedYes

Fingerprint

Phosphorylation
Glucagon
Protein Kinase C
Rats
Hepatocytes
Vasopressins
Adenylyl Cyclases
Glucagon Receptors
Membranes
Okadaic Acid
Staurosporine
Phosphoprotein Phosphatases
Level control
Cyclic AMP
Alkaline Phosphatase

Cite this

@article{183b62198a5f409b8dcef3ce3784f4a5,
title = "A role for protein kinase C-mediated phosphorylation in eliciting glucagon desensitization in rat hepatocytes",
abstract = "An immobilized hepatocyte preparation was used to show that both vasopressin and glucagon could desensitize the ability of glucagon to increase intracellular cyclic AMP concentrations. This process was not dependent on any influx of extracellular Ca2+ and was not mediated by any rise in the intracellular level of Ca2+. The protein kinase C-selective inhibitors chelerythrine, staurosporine and calphostin C acted as potent inhibitors of the desensitization process but with various degrees of selectivity regarding their ability to inhibit the desensitizing actions of glucagon and vasopressin. The protein phosphatase inhibitor okadaic acid was just as potent as vasopressin and glucagon in causing desensitization. Treatment of hepatocyte membranes with alkaline phosphatase restored to near control levels the ability of glucagon to stimulate adenylate cyclase activity in membranes from both glucagon- and vasopressin-treated (desensitized) hepatocytes. It is suggested that the desensitization of glucagon-stimulated adenylate cyclase activity involves a reversible phosphorylation reaction with the likely target being the glucagon receptor itself.",
author = "A. Savage and L. Zeng and Houslay, {M. D.}",
year = "1995",
month = "4",
day = "1",
doi = "10.1042/bj3070281",
language = "English",
volume = "307",
pages = "281--285",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "1",

}

A role for protein kinase C-mediated phosphorylation in eliciting glucagon desensitization in rat hepatocytes. / Savage, A.; Zeng, L.; Houslay, M. D.

In: Biochemical Journal, Vol. 307, No. 1, 01.04.1995, p. 281-285.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A role for protein kinase C-mediated phosphorylation in eliciting glucagon desensitization in rat hepatocytes

AU - Savage, A.

AU - Zeng, L.

AU - Houslay, M. D.

PY - 1995/4/1

Y1 - 1995/4/1

N2 - An immobilized hepatocyte preparation was used to show that both vasopressin and glucagon could desensitize the ability of glucagon to increase intracellular cyclic AMP concentrations. This process was not dependent on any influx of extracellular Ca2+ and was not mediated by any rise in the intracellular level of Ca2+. The protein kinase C-selective inhibitors chelerythrine, staurosporine and calphostin C acted as potent inhibitors of the desensitization process but with various degrees of selectivity regarding their ability to inhibit the desensitizing actions of glucagon and vasopressin. The protein phosphatase inhibitor okadaic acid was just as potent as vasopressin and glucagon in causing desensitization. Treatment of hepatocyte membranes with alkaline phosphatase restored to near control levels the ability of glucagon to stimulate adenylate cyclase activity in membranes from both glucagon- and vasopressin-treated (desensitized) hepatocytes. It is suggested that the desensitization of glucagon-stimulated adenylate cyclase activity involves a reversible phosphorylation reaction with the likely target being the glucagon receptor itself.

AB - An immobilized hepatocyte preparation was used to show that both vasopressin and glucagon could desensitize the ability of glucagon to increase intracellular cyclic AMP concentrations. This process was not dependent on any influx of extracellular Ca2+ and was not mediated by any rise in the intracellular level of Ca2+. The protein kinase C-selective inhibitors chelerythrine, staurosporine and calphostin C acted as potent inhibitors of the desensitization process but with various degrees of selectivity regarding their ability to inhibit the desensitizing actions of glucagon and vasopressin. The protein phosphatase inhibitor okadaic acid was just as potent as vasopressin and glucagon in causing desensitization. Treatment of hepatocyte membranes with alkaline phosphatase restored to near control levels the ability of glucagon to stimulate adenylate cyclase activity in membranes from both glucagon- and vasopressin-treated (desensitized) hepatocytes. It is suggested that the desensitization of glucagon-stimulated adenylate cyclase activity involves a reversible phosphorylation reaction with the likely target being the glucagon receptor itself.

U2 - 10.1042/bj3070281

DO - 10.1042/bj3070281

M3 - Article

VL - 307

SP - 281

EP - 285

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 1

ER -